132 related articles for article (PubMed ID: 16716595)
1. Molecular modeling of non-covalent binding of homochiral (3S,3'S)-astaxanthin to matrix metalloproteinase-13 (MMP-13).
Bikádi Z; Hazai E; Zsila F; Lockwood SF
Bioorg Med Chem; 2006 Aug; 14(16):5451-8. PubMed ID: 16716595
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the highly selective inhibition of MMP-13.
Engel CK; Pirard B; Schimanski S; Kirsch R; Habermann J; Klingler O; Schlotte V; Weithmann KU; Wendt KU
Chem Biol; 2005 Feb; 12(2):181-9. PubMed ID: 15734645
[TBL] [Abstract][Full Text] [Related]
3. Molecular modeling of binding between amidinobenzisothiazoles, with antidegenerative activity on cartilage, and matrix metalloproteinase-3.
Amadasi A; Cozzini P; Incerti M; Duce E; Fisicaro E; Vicini P
Bioorg Med Chem; 2007 Feb; 15(3):1420-9. PubMed ID: 17113299
[TBL] [Abstract][Full Text] [Related]
4. Structure of recombinant mouse collagenase-3 (MMP-13).
Botos I; Meyer E; Swanson SM; Lemaître V; Eeckhout Y; Meyer EF
J Mol Biol; 1999 Oct; 292(4):837-44. PubMed ID: 10525409
[TBL] [Abstract][Full Text] [Related]
5. QSAR analysis of some 5-amino-2-mercapto-1,3,4-thiadiazole based inhibitors of matrix metalloproteinases and bacterial collagenase.
Jamloki A; Karthikeyan C; Hari Narayana Moorthy NS; Trivedi P
Bioorg Med Chem Lett; 2006 Jul; 16(14):3847-54. PubMed ID: 16682189
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen peroxide-mediated downregulation of matrix metalloprotease-2 in indomethacin-induced acute gastric ulceration is blocked by melatonin and other antioxidants.
Ganguly K; Kundu P; Banerjee A; Reiter RJ; Swarnakar S
Free Radic Biol Med; 2006 Sep; 41(6):911-25. PubMed ID: 16934674
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase 11 (MMP-11; stromelysin-3) and synthetic inhibitors.
Matziari M; Dive V; Yiotakis A
Med Res Rev; 2007 Jul; 27(4):528-52. PubMed ID: 16710861
[TBL] [Abstract][Full Text] [Related]
8. Plasma appearance of unesterified astaxanthin geometrical E/Z and optical R/S isomers in men given single doses of a mixture of optical 3 and 3'R/S isomers of astaxanthin fatty acyl diesters.
Coral-Hinostroza GN; Ytrestøyl T; Ruyter B; Bjerkeng B
Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):99-110. PubMed ID: 15556071
[TBL] [Abstract][Full Text] [Related]
9. Prediction of interaction mode between a typical ACE inhibitor and MMP-9 active site.
Yamamoto D; Takai S; Miyazaki M
Biochem Biophys Res Commun; 2007 Mar; 354(4):981-4. PubMed ID: 17275782
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.
Nuti E; Panelli L; Casalini F; Avramova SI; Orlandini E; Santamaria S; Nencetti S; Tuccinardi T; Martinelli A; Cercignani G; D'Amelio N; Maiocchi A; Uggeri F; Rossello A
J Med Chem; 2009 Oct; 52(20):6347-61. PubMed ID: 19775099
[TBL] [Abstract][Full Text] [Related]
11. Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion.
Lee S; Park HI; Sang QX
Biochem J; 2007 Apr; 403(1):31-42. PubMed ID: 17176253
[TBL] [Abstract][Full Text] [Related]
12. A novel approach to measure the contribution of matrix metalloproteinase in the overall net proteolytic activity present in synovial fluids of patients with arthritis.
Simard N; Boire G; de Brum-Fernandes AJ; St-Pierre Y
Arthritis Res Ther; 2006; 8(4):R125. PubMed ID: 16859524
[TBL] [Abstract][Full Text] [Related]
13. Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.
Rudra DS; Pal U; Maiti NC; Reiter RJ; Swarnakar S
J Pineal Res; 2013 May; 54(4):398-405. PubMed ID: 23330737
[TBL] [Abstract][Full Text] [Related]
14. The chemistry of novel xanthophyll carotenoids.
Jackson H; Braun CL; Ernst H
Am J Cardiol; 2008 May; 101(10A):50D-57D. PubMed ID: 18474275
[TBL] [Abstract][Full Text] [Related]
15. Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents.
Supuran CT; Casini A; Scozzafava A
Med Res Rev; 2003 Sep; 23(5):535-58. PubMed ID: 12789686
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453.
Kohno T; Hochigai H; Yamashita E; Tsukihara T; Kanaoka M
Biochem Biophys Res Commun; 2006 May; 344(1):315-22. PubMed ID: 16603129
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases.
Faust A; Waschkau B; Waldeck J; Höltke C; Breyholz HJ; Wagner S; Kopka K; Heindel W; Schäfers M; Bremer C
Bioconjug Chem; 2008 May; 19(5):1001-8. PubMed ID: 18396900
[TBL] [Abstract][Full Text] [Related]
18. Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs.
Cuniasse P; Devel L; Makaritis A; Beau F; Georgiadis D; Matziari M; Yiotakis A; Dive V
Biochimie; 2005; 87(3-4):393-402. PubMed ID: 15781327
[TBL] [Abstract][Full Text] [Related]
19. Exploring the subtleties of drug-receptor interactions: the case of matrix metalloproteinases.
Bertini I; Calderone V; Fragai M; Giachetti A; Loconte M; Luchinat C; Maletta M; Nativi C; Yeo KJ
J Am Chem Soc; 2007 Mar; 129(9):2466-75. PubMed ID: 17269766
[TBL] [Abstract][Full Text] [Related]
20. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
